Revenue: The sum of all revenue fields included for a company's operating activities.
Altimmune, Inc. (ALT) had Revenue of $0.01M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$0.01M |
$-19.57M |
|
-- |
|
$0.01M |
|
$21.82M |
|
$-21.82M |
|
$1.56M |
|
$-20.26M |
|
$-20.26M |
|
$-19.57M |
|
$-19.57M |
|
$-19.57M |
|
$-19.57M |
|
$-21.82M |
|
$-22.47M |
|
75.55M |
|
75.55M |
|
$-0.26 |
|
$-0.26 |
|
| Balance Sheet Financials | |
$155.26M |
|
$0.38M |
|
$2.00M |
|
$157.26M |
|
$9.80M |
|
-- |
|
$5.30M |
|
$15.10M |
|
$142.16M |
|
$142.16M |
|
$142.16M |
|
77.83M |
|
| Cash Flow Statement Financials | |
$-16.84M |
|
$-5.10M |
|
$34.12M |
|
$36.97M |
|
$49.15M |
|
$12.18M |
|
$4.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.85 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-436300.00% |
|
-436300.00% |
|
-- |
|
-405120.00% |
|
-391500.00% |
|
$-16.84M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.00 |
|
0.04M |
|
-13.77% |
|
-13.77% |
|
-12.45% |
|
-13.77% |
|
$1.83 |
|
$-0.22 |
|
$-0.22 |
|